Login / Signup
Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease.
David K Choi
Archariya Puangampai
David T Rubin
Published in:
The Annals of pharmacotherapy (2022)
Keyphrases
</>
patients with inflammatory bowel disease
open label
metabolic syndrome
clinical trial
randomized controlled trial
adipose tissue
insulin resistance
study protocol